Bosh sahifaMVIR • STO
add
Medivir AB
Yopilish kursi
2,83 kr
Kunlik diapazon
2,75 kr - 2,90 kr
Yillik diapazon
2,33 kr - 4,71 kr
Bozor kapitalizatsiyasi
318,33 mln SEK
Oʻrtacha hajm
86,48 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 900,00 ming | 12,50% |
Joriy xarajat | 7,30 mln | 5,80% |
Sof foyda | -34,60 mln | -46,61% |
Sof foyda marjasi | -3,84 ming | -30,32% |
Har bir ulushga tushum | -0,30 | 28,57% |
EBITDA | -35,30 mln | -50,21% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 92,50 mln | 51,39% |
Jami aktivlari | 204,20 mln | 15,96% |
Jami passivlari | 62,40 mln | 20,93% |
Umumiy kapital | 141,80 mln | — |
Tarqatilgan aksiyalar | 112,17 mln | — |
Narxi/balansdagi bahosi | 2,25 | — |
Aktivlardan daromad | -40,60% | — |
Kapitaldan daromad | -53,35% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -34,60 mln | -46,61% |
Operatsiyalardan naqd pul | -33,40 mln | -59,05% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | -600,00 ming | 0,00% |
Naqd pulning sof oʻzgarishi | -34,10 mln | -57,14% |
Boʻsh pul | -21,80 mln | -71,32% |
Haqida
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Tashkil etilgan
1988
Sayt
Xodimlar soni
10
